Lymphoma Low-grade

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-01-19
Clinical Trial Update: Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 dose-ranging study evaluated pixantrone in the FND-R regimen for indolent non-Hodgkin lymphoma; the trial has completed.